methyl 2,4-dimethoxymethyloxybenzoate | 914298-92-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: methyl 2,4-dimethoxymethyloxybenzoate
• 英文别名: methyl 2,4-bis(methoxymethoxy)benzoate
• CAS: 914298-92-3
• 化学式: C₁₂H₁₆O₆
• 分子量: 256.255
• InChiKey: WGQXEZPYQZCQNL-UHFFFAOYSA-N

物化性质

• 沸点：
  361.0±42.0 °C(Predicted)
• 密度：
  1.159±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  18
• 可旋转键数：
  8
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  63.2
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  methyl 2,4-dimethoxymethyloxybenzoate 在 N-甲基吗啉 、 甲醇 、 lithium hydroxide 、 sodium hydroxide 、 calcium hypochlorite 、 水 、 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 溶剂黄146 、 N,N-二甲基甲酰胺 、 丙酮 为溶剂， 反应 48.0h， 生成 2-(5-chloro-2,4-bis-methoxymethoxybenzoyl)-2,3-dihydro-1H-isoindole-1-carboxylic acid
  参考文献：
  名称：

  WO2006/117669

  摘要：

  公开号：
• 作为产物：
  描述：

  2,4-二羟基苯甲酸甲酯 、 氯甲基甲基醚 在 N,N-二异丙基乙胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 12.0h， 以92%的产率得到methyl 2,4-dimethoxymethyloxybenzoate
  参考文献：
  名称：

  Dihydroxylphenyl amides as inhibitors of the Hsp90 molecular chaperone

  摘要：

  Information from X-ray crystal structures were used to optimize the potency of a HTS hit in a Hsp90 competitive binding assay. A class of novel and potent small molecule Hsp90 inhibitors were thereby identified. Enantio-pure compounds 31 and 33 were potent in PGA-based competitive binding assay and inhibited proliferation of various human cancer cell lines in vitro, with IC(50) values averaging 20 nM.

  DOI：

  10.1016/j.bmcl.2008.09.081

文献信息

• AMIDE RESORCINOL COMPOUNDS
  申请人：Funk Lee Andrew

  公开号：US20090215742A1

  公开（公告）日：2009-08-27

  The present invention is directed to compounds of formula (I), and pharmaceutically acceptable salts and solvates thereof, their synthesis, and their use as HSP-90 inhibitors.

  本发明涉及式(I)的化合物，以及其药学上可接受的盐和溶剂化物，它们的合成，以及它们作为HSP-90抑制剂的用途。
• Factors affecting orthogonality in the deprotection of 2,4-di-protected aromatic ethers employing solid-supported acids
  作者：Kassrin Tangdenpaisal、Supannee Sualek、Somsak Ruchirawat、Poonsakdi Ploypradith

  DOI：10.1016/j.tet.2009.03.089

  日期：2009.5

  Selective deprotection of aromatic ethers bearing two protecting groups on the same aromatic ring by solid-supported acids (Amberlyst-15 and PTS-Si) was systematically investigated. ortho-Directing protonation by the carbonyl group as well as carbocation stability and quenching are the important determining factors for the orthogonal deprotection process. Stablilized carbocations (e.g., those from the MOM and PMB groups) could be removed with high selectivity. (C) 2009 Elsevier Ltd. All rights reserved.
• [EN] AMIDE RESORCINOL COMPOUNDS<br/>[FR] COMPOSES D'AMIDE RESORCINOL
  申请人：PFIZER

  公开号：WO2006117669A1

  公开（公告）日：2006-11-09

  [EN] The present invention is directed to compounds of formula (I), and pharmaceutically acceptable salts and solvates thereof, their synthesis, and their use as HSP-90 inhibitors.
  [FR] L'invention porte sur des composés représentés par la formule (I), et sur des sels et des solvants de ceux-ci pharmaceutiquement acceptables, sur leur synthèse et leur utilisation en tant qu'inhibiteurs HSP-90.
• [EN] AMIDE RESORCINOL COMPOUNDS<br/>[FR] COMPOSÉS D'AMIDE RÉSORCINOL
  申请人：PFIZER PROD INC

  公开号：WO2008053319A1

  公开（公告）日：2008-05-08

  [EN] The present invention is directed to amide resorcinol compounds and pharmaceutically acceptable salts and solvates thereof, their synthesis, and their use as HSP-90 inhibitors.
  [FR] La présente invention concerne des composés d'amide résorcinol et leurs sels et solvates pharmaceutiquement acceptables, leur synthèse et leur utilisation en tant qu'inhibiteurs de HSP-90.
• Dihydroxylphenyl amides as inhibitors of the Hsp90 molecular chaperone
  作者：Pei-Pei Kung、Lee Funk、Jerry Meng、Michael Collins、Joe Zhongxiang Zhou、M. Catherine Johnson、Anne Ekker、Jeff Wang、Pramod Mehta、Min-Jean Yin、Caroline Rodgers、Jay F. Davies、Eileen Bayman、Tod Smeal、Karen A. Maegley、Michael R. Gehring

  DOI：10.1016/j.bmcl.2008.09.081

  日期：2008.12

  Information from X-ray crystal structures were used to optimize the potency of a HTS hit in a Hsp90 competitive binding assay. A class of novel and potent small molecule Hsp90 inhibitors were thereby identified. Enantio-pure compounds 31 and 33 were potent in PGA-based competitive binding assay and inhibited proliferation of various human cancer cell lines in vitro, with IC(50) values averaging 20 nM.